Kuldeep Neote Senior Director, New Ventures J&J
Gregory Naeve Head, Strategic Research Partnerships, San Francisco Pfizer
Brad Loncar Portfolio Manager Loncar Cancer Immunotherapy ETF
Biren Amin MD Jefferies LLC
Reni Benjamin SVP Global Rare Diseases Raymond James Financial
Art Krieg CEO Checkmate Pharmaceuticals
Alex Lewis Director, Corporate Activities & Strategy Oxford BioMedica
Rob Hart Principal Telegraph Hill Partners
Bart Wuurman, PharmD Chief Executive Officer DDF Ventures bv
Sue Washer CEO AGTC
Harpreet Singh Chief Executive Officer Immatics US, Inc
Fraser Wright Co-Founder & Chief Technology Officer Spark Therapeutics
Nate Beyor VP, Corporate Development Asterias Biotherapeutics
David Spencer Chief Scientific Officer Bellicum Pharmaceuticals
Timothy Moore Executive Vice President of Technical Operations Kite Pharma
Antonin de Fougerolles CSO Ablynx
Thomas Hoeger CEO Apogenix AG
Mark Throsby CSO Merus
Robert Shaw Vice President and General Manager for Cell Culture and Cell Therapy, BioProduction Division Thermo Fisher Scientific
Sandra Glucksmann Chief Operating Officer Editas Medicine
Stephen Maietta Head of Market Development Envirotainer
William Podd Founder, President, CEO Landmark Angels
Eric Soller Entrepreneur in Residence Versant Ventures
Gregory Bonfiglio Founder & Managing Partner Proteus
Scott Ohansian SVP Commercial Operations, Clinical Trial Logistics QuickSTAT